Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

van der Schoot LS, Atalay S, Otero ME, Kievit W, et al. Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab. Br J Dermatol 2022 Jul 27. doi: 10.1111/bjd.21797.
PMID: 35895852


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016